ESC Premium Access

Current controversies in clinical trial design - Panel discussion.

Topic: Cardiovascular Pharmacotherapy

Congress Presentation

3 more presentations in this session

Critical issues in endpoint definition.

Speaker: Professor J. Tijssen (Amsterdam, NL)


Lost to follow-up in cardiovascular trials.

Speaker: Associate Professor V. Serebruany (Baltimore, US)


Can we avoid randomized clinical trials for new CV drugs? .

Speaker: Ms K. Pieper (London, GB)


Access the full session

Current controversies in clinical trial design

Speakers: Professor J. Tijssen, Associate Professor V. Serebruany, Ms K. Pieper

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb